Clinical Trial Update: A Trial of Memantine as Symptomatic Treatment for Early Huntington Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating memantine as symptomatic treatment for early Huntington disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: University of British Columbia | Conditions: Huntington Disease | Phase 2 | Status: COMPLETED